Fundraising Fox
quadraScope Venture Fund
Venture capitalActively deployingBoston · 17 people tracked
Find your way into quadraScope Venture Fund
294 people in our graph can introduce you to the quadraScope Venture Fund team.
Sign up to see every warm intro you have to quadraScope Venture Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the quadraScope Venture Fund team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
quadraScope focuses on the emerging longevity and rejuvenation healthcare market, grounded in the science of biogerontology and the Hallmarks of Aging framework. It backs companies developing pharmaceuticals, diagnostics, software, equipment and devices that enable disease treatment and prevention through biological age reversal. The firm invests across a diversified portfolio at various preclinical and clinical development stages, targeting technologies that extend human healthspan and lifespan while also addressing diseases that lack treatments. Leveraging strategic locations in Boston and Tel-Aviv, it aims to tap into concentrations of biotech academia, industry and scientific talent, and has also supported the formation of rejuvenation clinics and treatment protocols alongside clinical trials.
Source: firm website, verified Sep 26, 2026.
Team · 17 people
from the firm's website & public directories
What they invest in
from 10 of 12 portfolio companiesBiotech ×8Longevity ×6Healthtech ×5Digital Health ×4AI & Machine Learning ×3Deep Tech ×2Medical Devices ×2Wellness & Fitness ×1
HQs:United States×6
Investments · 12 tracked
founders shown can be your intro pathBy year:2026 · 12019 · 12 dated
HealthtechMiami, US
Agustin Fernandez Santana III(Executive Officer, Director)Jeffrey B. Madden(Executive Officer, Director)inDavid Buchsbaum(Executive Officer)Frank Mattner(Director)
BoardWalter Schmidt(Director)
Alden Scientific is a biotech company with over 40 scientists, bioinformaticians, engineers, clinicians, and researchers developing immunological research capabilities.
AI & Machine LearningBiotechDigital HealthCambridge, US
James Heywood(CEO & Founder)
Co-investorsDeep FutureiSelect FundService Provider Capital
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsBioGenerator VenturesLifespan Vision VenturesMissouri Technology Corporation
Cosmica builds OrganAge™, a blood-based biomarker tool that scores biological aging across nine physiological systems, and an intervention engine that ranks foods, supplements, and activities by how they act on a person's aging-related genes.
BiotechDigital HealthLongevity
David Furman(Founder & Chief Executive Officer)Abhay Saini(Co-founder & Chief Operating Officer)inFei Wu(Chief Scientific Officer)
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Lifespan Vision VenturesMana Ventures+2 more
A clinic offering personalized longevity medicine programs designed to extend healthspan through scientifically-proven interventions, combining advanced diagnostics and therapies sourced from cutting-edge research.
Digital HealthHealthtechLongevityWellness & FitnessMiami, US
Petr Sramek(Co-founder & Managing Partner)
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)inHans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSLifespan Vision VenturesRemiges Ventures, Inc.
Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol.
BiotechHealthtechMedical DevicesSyracuse, US
Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)
BoardKelsey Moody(Director)
Co-investorsMethuselah FoundationThynk Capital
Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease.
AI & Machine LearningBiotechDeep TechLongevity
Co-investorsAlumni VenturesBeiersdorf Innovation FundBeresford VenturesDraper AssociatesFreemind InvestmentsPortal Innovations
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Matter BioNanotics
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has quadraScope Venture Fund made?
- quadraScope Venture Fund has 12 tracked investments, including 1 dated in the last 24 months.
- What sectors does quadraScope Venture Fund focus on?
- quadraScope Venture Fund focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is quadraScope Venture Fund located?
- quadraScope Venture Fund is headquartered in Boston, US.
- Who does quadraScope Venture Fund co-invest with?
- quadraScope Venture Fund most often shares deals with Lifespan Vision Ventures, Bold Capital Partners, BioGenerator Ventures, among 24 tracked co-investors.
Media · Podcasts & interviews
from their channelLongevity Nation 2025
quadraScope Ventures
Mitochondrial dysfunction
quadraScope Ventures
Chronic inflammation
quadraScope Ventures
BioChange – transforming tissue regeneration
quadraScope Ventures
Maintaining mitochondrial health – interview with Dr. Behrouz, co-founder & CEO @ Vincere Bio
quadraScope Ventures
Key trends in longevity science and market – 2024 Longevity Nation Conference
quadraScope Ventures
Images
Co-investors · 2
Cyberstarts is a venture capital firm that partners with cybersecurity founders from day one, using a systematic process and an extensive CISO network to help build industry-defining cybersecurity companies.
Esplanade Ventures is a Canadian digital health venture capital firm that invests early in technology companies transforming healthcare delivery across the U.S. and Canada.
Firms observed investing alongside quadraScope Venture Fund, from public investor directories. Shared companies are the overlap with quadraScope Venture Fund's recorded portfolio.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.